FIELD: medicine, oncology.
SUBSTANCE: before the onset and 10-14 d after the end of chemotherapy course it is necessary to carry out chromatic Doppler mapping to evaluate maximal tumor rate of circulation, and at its decreased value being 25% lower against initial data one should establish process stabilization, and at its increase being 25% higher against the initial data - process progressing should be stated upon. The innovation enables to objectively evaluate efficiency of chemotherapy at applying safe, simple ultrasound trial for the purpose to specify subsequent therapeutic tactics.
EFFECT: higher efficiency and accuracy of detection.
8 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING MAMMARY GLAND CARCINOMA SENSITIVITY TO CHEMOTHERAPY | 1999 |
|
RU2161444C1 |
| METHOD OF DIAGNOSING RETROPERITONEAL TUMOURS IN CHILDREN | 2010 |
|
RU2427320C1 |
| METHOD FOR PREDICTING INDIVIDUAL TUMOR SENSITIVITY TO CHEMOTHERAPY | 2000 |
|
RU2179725C2 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF NEOADJUVANT AUTOMYELOCHEMOTHERAPY IN PATIENTS WITH RECURRENT BREAST CANCER | 2008 |
|
RU2393484C1 |
| ULTRASONIC METHOD FOR PREDICTING NON-HODGKIN'S LYMPHOMA TREATMENT | 2001 |
|
RU2211665C2 |
| ULTRASONIC DIAGNOSTIC TECHNIQUE FOR LOCAL RECURRENT OVARIAN CANCER | 2012 |
|
RU2498773C2 |
| METHOD OF TREATMENT OF PATIENTS WITH BREAST CANCER | 1998 |
|
RU2145239C1 |
| METHOD FOR EVALUATING THERAPEUTIC EFFICIENCY AT UTERINE CERVIX CANCER | 2005 |
|
RU2290065C1 |
| METHOD FOR CARRYING OUT ULTRASONIC DIAGNOSTIC EXAMINATION FOR DETERMINING INDIVIDUAL RESIDUAL OVARIAN TUMOR SENSITIVITY TO CHEMOTHERAPY | 2002 |
|
RU2239362C2 |
| METHOD FOR PRODUCING ULTRASONIC ANTRACYCLINE- INDUCED CARDIOTOXICITY EVALUATION IN ONCOLOGICAL PATIENTS | 2002 |
|
RU2225166C2 |
